FDA Clearance Tracker · DEN200028
Lumenis Stellar M22
Last checked: Nov 19, 2026Latest source record: Feb 23, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Feb 23, 2021
De Novo granted
Time to decision
309 days
Received Apr 20, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN200028
- Device name
- Lumenis Stellar M22
- Applicant
- Lumenis, Ltd.
- Applicant location
- Yokneam, IL
- Received
- Apr 20, 2020
- Decided
- Feb 23, 2021
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 886.5201
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN200028
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Lumenis, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K212703 · Decided Oct 19, 2021 · 54 days after receipt
Device type: Powered Laser Surgical Instrument (GEX) · General & Plastic Surgery
K203544 · Decided Dec 24, 2020 · 20 days after receipt
Device type: Powered Laser Surgical Instrument (GEX) · General & Plastic Surgery
K202428 · Decided Oct 22, 2020 · 58 days after receipt
Device type: Powered Laser Surgical Instrument (GEX) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.